Cumulative Success Rate of IVF in Thailand: Age and Embryo Factors Determine Individual Differences
Document header information
The cumulative success rate (cumulative live birth rate) of IVF in Thailand is not a fixed number but an individualized indicator determined by the patient's age, ovarian reserve, embryo chromosomal normality rate, and the laboratory technology of the fertility center. In Thai fertility centers with internationally certified laboratory conditions, the single-cycle cumulative live birth rate for patients under 35 is approximately 50-65%, for ages 35-38 it is about 40-50%, for ages 39-42 it is about 20-35%, and it decreases significantly for those over 42. The cumulative success rate reflects the probability of ultimately achieving a live birth after multiple transfers starting from a complete egg retrieval cycle, making it a more valuable assessment metric than the single transfer success rate. When choosing a fertility center, attention should be paid to its cumulative live birth rate data rather than single success rate claims.
The Most Easily Overlooked Detail: How the Cumulative Success Rate is Calculated
In clinical consultations, I find that most patients understand "success rate" only at the level of "succeeding with one transfer." In reality, there are two key indicators in the field of assisted reproduction: single transfer live birth rate and cumulative live birth rate (CLBR).
The single transfer live birth rate refers to the probability of achieving a live birth after one embryo transfer. This number is usually higher because it only counts cycles where a transfer was possible. In contrast, the cumulative live birth rate calculates the probability of ultimately achieving a live birth from the start of a complete egg retrieval cycle, including all fresh and frozen-thawed embryo transfers. It more accurately reflects the final outcome of a treatment cycle.
Some fertility centers tend to use the single transfer success rate in their promotions because the numbers look better. However, from the patient's perspective, what truly matters is the cumulative live birth rate—it tells you: "If I undergo one egg retrieval, what is the probability of eventually taking a baby home?" This indicator directly determines treatment efficiency and overall cost.
A 34-year-old patient with an AMH of 2.8 ng/mL had 8 embryos from one egg retrieval. After PGT-A screening, 3 euploid embryos were obtained. The first transfer did not result in implantation, but the second transfer led to a successful live birth. The single transfer success rate was 50% (1 success out of 2 transfers), but the cumulative live birth rate was 100% (the cycle ultimately succeeded). Looking only at the single transfer success rate would underestimate the actual effectiveness of this cycle.
What is the Cumulative Success Rate of IVF in Thailand? A Direct Answer
There is no single universal number for the cumulative success rate of IVF in Thailand that applies to everyone. Based on international assisted reproductive technology monitoring data (ESHRE, CDC, SART, etc.) and clinical reports from Thai fertility centers with international accreditations (such as JCI, RTAC), the reference ranges are as follows:
| Age Group | Single-Cycle Cumulative Live Birth Rate Reference Range | Main Limiting Factors |
|---|---|---|
| < 35 years | 50% – 65% | Lower embryo chromosomal abnormality rate, better ovarian reserve |
| 35 – 38 years | 40% – 50% | Egg quality begins to decline, euploidy rate approximately 40-50% |
| 39 – 42 years | 20% – 35% | Increased egg chromosomal abnormality rate, fewer embryos obtained |
| > 42 years | < 15% | Significant decline in both egg quality and quantity; egg donation should be considered |
Special Note: The above data represents the level of fertility centers with good laboratory conditions and assumes normal uterine environment and no severe endocrine or immune diseases in the patient. Actual cumulative success rates may vary due to individual differences, center technology levels, and ovarian stimulation protocols. Some centers in Thailand have extensive experience in PGT-A technology and cryopreservation techniques, which can positively impact the cumulative success rate for specific populations (e.g., advanced age, repeated implantation failure), but they do not change the core variable of age.
How Doctors View the Cumulative Success Rate
In clinical reproductive medicine decision-making, the cumulative success rate is an important basis for formulating treatment strategies, but it is not used as a promise to patients. What we focus on more is: How to maximize the cumulative live birth rate within a single egg retrieval cycle.
From a doctor's perspective, the key to improving the cumulative success rate lies in three aspects:
- Individualized Ovarian Stimulation Protocols: Choose the most suitable protocol based on AMH, FSH, and antral follicle count (AFC). The goal is to obtain a sufficient number of high-quality eggs, not to maximize the number of follicles.
- Embryo Utilization Rate: Screen for chromosomally normal embryos through PGT-A to reduce ineffective transfers. However, the potential embryo loss from biopsy and cryopreservation must be weighed.
- Endometrial Receptivity Assessment: Before transfer, use hysteroscopy, ERA (Endometrial Receptivity Analysis), and other tests to rule out uterine factors, preventing implantation failure of good-quality embryos due to endometrial issues.
In Thailand, due to the widespread application of PGT-A technology, doctors can more accurately screen for euploid embryos, which can theoretically improve the implantation rate per transfer and thus positively influence the cumulative success rate. However, this advantage is mainly seen in centers with high-quality embryology laboratories.
Differences Across Age Groups
Age is the primary weighting factor affecting the cumulative success rate, and its mechanism is mainly reflected in the egg chromosomal abnormality rate.
Under 35
The egg euploidy rate is approximately 50-65%, ovarian reserve is usually sufficient, and more embryos can be obtained from a single egg retrieval. The cumulative success rate is highest and is relatively less correlated with the technology level of the fertility center—even with average laboratory conditions, there is a high probability of success.
35-38 Years
The egg euploidy rate begins to decline to 40-50%, and individual differences in ovarian reserve increase. The cumulative success rate is still relatively high but begins to depend significantly on laboratory technology and embryo screening capabilities. In centers with PGT-A capabilities, the cumulative success rate can approach that of the younger group.
39-42 Years
The egg euploidy rate drops to 20-35%, and the number of embryos obtained decreases significantly. The cumulative success rate mainly depends on whether at least one euploid embryo can be obtained. Some centers in Thailand can improve the cumulative success rate to a certain extent through mild stimulation protocols or multiple egg retrievals to accumulate embryos.
Over 42 Years
The egg euploidy rate is usually below 15%, and the cumulative live birth rate decreases significantly. For this age group, if insisting on using their own eggs, multiple egg retrievals are often needed to accumulate embryos. Thailand allows legal egg donation, which is an effective way to improve the cumulative success rate for patients with severely diminished ovarian function.
Differences Between Thailand and Other Countries
Thailand's technical characteristics and legal environment in the field of assisted reproduction give it specific advantages in cumulative success rates for certain populations, but the core determining factor remains the patient's own condition.
| Comparison Dimension | Thailand | Domestic (China) | United States |
|---|---|---|---|
| PGT-A Application | Allowed and widely used | Restricted, requires strict indications | Routine application |
| Egg Donation Policy | Legal, with a clear legal framework | Restricted, long waiting times | Legal, mature process |
| Laboratory Accreditation | Some centers have JCI/RTAC | Strict standards for tertiary hospital labs | CAP/CLIA accreditation common |
| Cumulative Success Rate (under 35) | 50-65% (accredited centers) | 45-60% (large centers) | 55-70% (accredited centers) |
| Cost Gradient | Medium | Lower (partial insurance coverage) | High |
Thailand legally permits PGT-A and egg donation, allowing patients of advanced age, those with repeated implantation failure, or carriers of chromosomal abnormalities to access technical services in Thailand that may be restricted domestically, thereby improving the cumulative success rate for this group. However, it is important to note that policy advantages do not equal technical advantages; when choosing a center, it is still necessary to verify its laboratory quality and clinical data.
Interpretation of Key Examination Indicators
The following indicators are closely related to the cumulative success rate of IVF in Thailand. It is recommended to complete the assessment before treatment:
- AMH (Anti-Müllerian Hormone): Reflects ovarian reserve quantity. AMH < 1.0 ng/mL suggests diminished ovarian reserve, potentially reducing the number of eggs retrieved, and the cumulative success rate may be limited by the number of embryos. AMH > 3.0 ng/mL requires caution for Polycystic Ovary Syndrome (PCOS); while many eggs may be retrieved, egg quality might decline.
- FSH (Follicle-Stimulating Hormone): Basal FSH > 10 IU/L indicates decreased ovarian function, potentially poor response to ovarian stimulation medications, affecting the number of embryos obtained.
- LH (Luteinizing Hormone): An FSH/LH ratio > 2.0 suggests diminished ovarian reserve, requiring attention to the choice of ovarian stimulation protocol.
- Antral Follicle Count (AFC): Bilateral AFC < 5 indicates insufficient ovarian reserve, and the cumulative success rate may be limited by the number of embryos.
- Semen Analysis: Male sperm concentration, motility, morphology, and DNA fragmentation index (DFI) all affect fertilization rate and embryo quality. DFI > 30% may reduce blastocyst formation rate and cumulative success rate.
- Chromosomal Karyotype Analysis: Structural chromosomal abnormalities in either partner (e.g., balanced translocation, Robertsonian translocation) significantly reduce the embryo euploidy rate, making PGT-SR a necessary technical choice.
Before undergoing IVF treatment in Thailand, it is recommended to provide the above examination reports to the fertility center for a preliminary evaluation. The doctor will estimate the possible range of the cumulative success rate based on the indicators and formulate an individualized plan.
Common Pitfalls to Avoid
In IVF consultations in Thailand, I find that patients are most easily misled by the following information:
- Misled by "Single Transfer Success Rate": Some centers advertise an "80% success rate," but upon closer inspection, the fine print says "single transfer clinical pregnancy rate." The clinical pregnancy rate is not the live birth rate, and the single transfer success rate does not reflect the final outcome of a cycle. The cumulative live birth rate is the truly valid data.
- Ignoring "Embryo Cryopreservation Loss": Success rates reported by some centers do not account for the loss after thawing frozen embryos. There is a 5-15% loss rate during the freezing and thawing process, which affects the actual cumulative success rate. Centers should be asked to provide complete data "from egg retrieval to live birth".
- Considering "Positive HCG" as Success: Biochemical pregnancies (positive HCG but not developing into a clinical pregnancy) are sometimes counted as "success" in some promotions. Biochemical pregnancies have a high rate of early miscarriage and do not represent a final live birth. The live birth rate should be requested as the statistical endpoint.
- Ignoring "Cycles Without Transfer": Some centers only count cycles where an embryo transfer occurred, excluding cycles canceled due to "no available embryos" from the denominator. This results in an inflated cumulative success rate. The correct denominator for the cumulative success rate should include all cycles that started ovarian stimulation.
In 12 years of practice, I have observed that what truly affects the cumulative success rate is often not the technology itself, but the patient's cognitive bias regarding their own condition. A 40-year-old patient with an AMH of only 0.8, after consulting multiple centers, chose to believe the "60% success rate" advertisement. She underwent two egg retrievals but had no usable embryos. If she had rationally evaluated the cumulative success rate from the start, she might have chosen a different treatment strategy (such as egg donation). Establishing reasonable expectations is a crucial prerequisite for improving treatment satisfaction.
Practitioner's Observation: Viewing the Cumulative Success Rate Rationally
As a reproductive doctor, I recommend evaluating the cumulative success rate of IVF in Thailand rationally from the following perspectives:
- The cumulative success rate is a "population statistic," not a "personal promise": Even within the same center and the same age group, individual differences can be significant. The value of statistical data lies in helping doctors choose the optimal plan, not in predicting an individual's outcome.
- Focus on the center's quality accreditation, not its advertisements: Fertility centers in Thailand accredited by JCI (Joint Commission International) or RTAC (Reproductive Technology Accreditation Committee) tend to have more transparent and reliable data. Centers should be asked to provide age-stratified cumulative live birth rates, not just overall data.
- The cumulative success rate is directly related to "treatment efficiency": A center with a high cumulative success rate usually means a higher probability of achieving a live birth from a single egg retrieval, resulting in less overall treatment time and cost. For patients requiring multiple transfers, the cumulative success rate has greater economic consideration value than the single success rate.
- The "applicable boundaries" of technological advantages: Technologies like PGT-A, ERA, and AI embryo scoring can indeed improve the cumulative success rate, but they primarily address "embryo screening" and "transfer timing" issues and cannot change the quality of the eggs themselves. For patients with severely diminished ovarian function, the advantages of these technologies are limited.
In IVF treatment in Thailand, a rational decision-making path is: first, assess your own condition (age, AMH, AFC, chromosomes, etc.), then choose a center and technical plan that matches your condition, and finally, set reasonable expectations based on the center's cumulative success rate data. Do not blindly follow "high success rate" advertisements, nor underestimate the advantages if your own conditions are favorable.
End: Risk ReminderThe cumulative success rate is a statistical indicator based on population data and does not constitute a prediction or promise of individual treatment outcomes. Individual differences exist in assisted reproductive treatment; even if all conditions are ideal, 100% success cannot be guaranteed. For individuals of advanced age (especially over 42), those with severely diminished ovarian reserve (AMH < 0.5 ng/mL), or those with severe uterine diseases or immune abnormalities, the cumulative success rate may be significantly lower than the reference range. Before undergoing treatment in Thailand, it is recommended to verify the fertility center's accreditation qualifications and clinical data through official channels and request age-stratified cumulative live birth rate statistics. Any claims of "guaranteed success" or "high success rate guarantee" are not in line with medical ethics and should be carefully scrutinized.
